神经介入巨头泰尔茂收购SequentM
2019-1-12 来源：不详 浏览次数：次泰尔茂公司前日宣布已进入签订协议环节收购SequentMedicalInc.，该公司是一家开发治疗脑动脉瘤栓塞器械的美国私有企业。此次收购金额为2.8亿美元，如果完成设定的里程碑，最高将再追加支付1亿美元。此次收购是泰尔茂在建立和扩大在脑神经血管和其他快速增长细分市场的关键战略。
泰尔茂把前景看好的脑血管内治疗和导管治疗视作两大重点领域。
详细新闻如下：
TerumoAcquiresSequentMedical,U.S.-basedDeveloperofNewAneurysmEmbolizationDevice-AcceleratingGrowthinNeurovascularTreatment
TerumoCorporation(Headquarters:Tokyo,Japan;PresidentandCEO:YutaroShintaku)announcedtodaythatithasenteredintoanagreement(hereaftertheacquisition)topurchaseSequentMedical,Inc.(California,UnitedStates;hereafterSequent),aprivately-heldfirmdevelopinganewmedicaldeviceforaneurysmembolization.
Thepurchasepriceof$millionwillbepaidatclosing,withupto$millionmoretobepaidbasedontheachievementofspecificdevelopmentor北京哪家医院治疗白癜风白癜风北京
